Target intelligence / Profile preview

Prefoldin subunit 4 pseudogene 1 (PFDN4P1)

Target
PFDN4P1
Molecular classification
Other (pseudogene)
01

Overview

PFDN4 pseudogene 1 (PFDN4P1) is a genomic element in humans categorized as a pseudogene that is homologous to the *prefoldin subunit 4* gene (PFDN4). Pseudogenes like PFDN4P1 are often unable to code for a functional protein and are typically regarded as non-functional relics of evolution. They are not the focus of pharmacological interventions, do not encode receptors or enzymes, and are not considered validated therapeutic targets.

Other names
PFDN4 pseudogene 1prefoldin subunit 4 pseudogenePFDN4P1

Beyond the preview

Go deeper on Prefoldin subunit 4 pseudogene 1 (PFDN4P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prefoldin subunit 4 pseudogene 1 (PFDN4P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call